A Pap smear report noting a “predominance of coccobacilli” or a “shift in vaginal flora” is telling you that the usual population of rod-shaped lactobacilli in the vagina has been overtaken by shorter, rounder bacteria. In practical terms, this finding is the cytologist’s way of flagging probable bacterial vaginosis, or BV. It is one of the most common results that sends people to a search engine after an otherwise routine screening, and while it is not a cancer diagnosis, it is worth understanding because the flora shift it describes has real downstream effects on vaginal health, pregnancy outcomes, and susceptibility to other infections.
What Coccobacilli Are and Why They Show Up on a Pap Smear
Coccobacilli are bacteria shaped like short rods or ovals, sitting somewhere between perfectly round cocci and elongated bacilli. They can even be mistaken for round bacteria because of how stubby they are.1Osmosis. Coccobacilli · What Are The, Treatment, and More In the context of a vaginal Pap smear, the term almost always refers to organisms associated with BV, particularly Gardnerella vaginalis and related species. A healthy vaginal smear is dominated by large, rod-shaped lactobacilli. When those rods are replaced by a dense coating of tiny coccobacilli clinging to the surface of epithelial cells, cytologists describe it as a “shift in flora.” Those bacteria-coated cells are sometimes called clue cells, and their presence is one of the classic hallmarks of BV.
The Pap smear was designed to screen for cervical cancer, not to diagnose infections. But because the cytologist is already examining vaginal cells under a microscope, a dramatic change in the surrounding bacterial landscape is hard to miss. Labs report it as a descriptive finding, and your clinician then decides whether further testing or treatment is warranted.
What Drives the Shift Away From Lactobacilli
The vagina is normally an acidic environment, kept that way by lactobacilli that ferment glycogen into lactic acid. When those lactobacilli lose their foothold, the pH rises, and a mixed community of anaerobic bacteria fills the gap. Gardnerella vaginalis is a central player in this process and contributes to the formation of a biofilm on the vaginal wall.2PubMed Central. Prospective study of vaginal samples for the detection of Gardnerella vaginalis and G. swidsinskii/leopoldii using Gardnerella agar in CO2 and anaerobic atmospheres But Gardnerella does not act alone. Research on different Gardnerella species shows they work together synergistically, with certain combinations proving especially effective at displacing protective Lactobacillus crispatus from vaginal cells.3PubMed Central. Gardnerella species exhibit synergy in their ability to displace Lactobacillus crispatus adhered to HeLa cells This is one reason BV is now understood as a polymicrobial condition rather than a single-organism infection.
Several behavioral and environmental factors raise the odds of this shift happening. Having multiple sexual partners, douching, smoking, and using an intrauterine device have all been linked to higher BV risk.4PubMed. Bacterial vaginosis. Epidemiology and risk factors A study of women of reproductive age in Lagos found that having more than one sexual partner roughly doubled the odds of BV, and douching also raised risk.5PubMed Central. Prevalence and associated risk factors of bacterial vaginosis among women of reproductive age living with, and without HIV in Lagos, Nigeria Douching is especially counterproductive because it physically washes out the lactobacilli that are keeping the vaginal ecosystem stable. Using scented soaps in the genital area carries a similar risk.
How Reliable Is the Pap Smear at Detecting BV
If you received this result on a Pap smear, a fair question is: how much should you trust it? The gold standard for diagnosing BV in a research setting is a Gram-stained smear scored using the Nugent system, which counts the relative proportions of bacterial morphotypes under a microscope. The Pap smear is not specifically designed for this, and its accuracy varies across studies.
One study comparing Pap smear results to Nugent-scored Gram stains found the Pap had a sensitivity of about 71% and a specificity of about 57% for BV.6PubMed Central. Reliability of conventional Papanicolaou smear in diagnosing bacterial vaginosis among women with clinical genital infection That means it catches most cases but also flags a fair number of women who do not actually have BV by the stricter standard. A larger study of over 1,100 women found somewhat different numbers: lower sensitivity at about 55% but much higher specificity at 94%, with an overall accuracy around 82%.7Texto & Contexto – Enfermagem. PAP SMEAR PERFORMANCE IN BACTERIAL VAGINOSIS DIAGNOSIS The agreement between Pap smear and Gram stain was rated as moderate.
What this means for you: a Pap smear that says “shift in flora” or “predominance of coccobacilli” is a useful signal, but it is not definitive on its own. If you have symptoms like unusual discharge or a fishy odor, the clinical picture and the Pap finding together make BV very likely, and your clinician will often treat based on that combination. If you have no symptoms at all, the finding may prompt a conversation rather than immediate antibiotics. Some clinicians will order a confirmatory test, such as a vaginal pH measurement, a whiff test, or a dedicated BV panel.
Why This Finding Matters Beyond Symptoms
Many people with a coccobacilli-predominant flora have no noticeable symptoms, and it can be tempting to dismiss the finding as unimportant. But BV has consequences that go beyond the classic thin discharge and fishy odor. The shift in bacterial populations triggers an inflammatory response, and BV-associated bacteria produce enzymes like sialidase and prolidase that break down protective mucous barriers.8PubMed. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis In pregnant women with BV, these same enzymes are strongly associated with elevated levels of the inflammatory molecule IL-1β, which is linked to tissue damage and adverse pregnancy outcomes.9PubMed. Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta
A large analysis of Pap smear results also found a striking association with cervical abnormalities. Among smears showing BV, about 10% had pre-cancerous cervical lesions, compared to roughly 6% of smears with normal flora. The odds of finding cervical intraepithelial neoplasia were nearly twice as high in women with BV.10PubMed Central. Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Is there an Association or is Co-Existence Incidental? This does not mean BV causes cervical cancer, but the association is strong enough to warrant attention, possibly because the disrupted vaginal environment makes it easier for HPV to persist.
Pregnancy Risks and the Coccobacilli Finding
For pregnant women, a Pap smear showing a flora shift carries additional weight. A case-control study of 186 women with histologically confirmed chorioamnionitis (infection of the fetal membranes) found that their prenatal Pap smears were significantly more likely to show altered vaginal flora. Preterm delivery was also more common among women whose Pap smears showed the shift.11Diagnostic Cytopathology. Association between a shift in vaginal flora on papanicolaou smear and acute chorioamnionitis and preterm delivery
Another study looking specifically at coccobacilli on Pap smears found a modest overall increase in the risk of small-for-gestational-age babies. But the timing of the finding mattered enormously. When coccobacilli were detected on a Pap smear within four weeks of delivery, the risk of very preterm birth (at or before 31 weeks) jumped more than fourfold.12PubMed. Signs of infection in Pap smears and risk of adverse pregnancy outcome That finding suggests early detection and treatment during the second trimester could reduce the risk of extremely premature delivery. If you are pregnant and your Pap smear mentions coccobacilli, bring it up with your provider even if they do not raise it first.
The Biofilm Problem and Recurrence
One of the most frustrating aspects of BV is how often it comes back. Standard antibiotic treatment with metronidazole or clindamycin clears the immediate overgrowth, but recurrence rates are notoriously high, with many women experiencing a return of symptoms within a few months. The reason lies largely in the biofilm that BV-associated bacteria form on the vaginal wall. A biofilm is a structured community of bacteria embedded in a sticky matrix that shields them from both antibiotics and the immune system. Gardnerella species are central architects of this biofilm, and their synergistic behavior makes it especially resilient.3PubMed Central. Gardnerella species exhibit synergy in their ability to displace Lactobacillus crispatus adhered to HeLa cells
Antibiotics can knock back the free-floating bacteria and reduce symptoms, but they often fail to fully eradicate the biofilm. Once antibiotic treatment ends, the surviving bacteria within the biofilm can repopulate the vaginal environment. This is why researchers have been exploring strategies beyond standard antibiotics, including probiotics, prebiotics, acidifying agents, antiseptics, plant-derived compounds, vaginal microbiota transplantation, and even phage endolysins (enzymes derived from viruses that specifically target bacteria).13PubMed Central. Fighting polymicrobial biofilms in bacterial vaginosis Most of these are still in early stages of research, but they reflect a growing recognition that simply killing the bad bacteria is not enough if you cannot also help the good bacteria reclaim their territory.
Probiotics and Restoring Lactobacilli
Probiotic lactobacilli have attracted the most attention as a way to help restore a healthy vaginal flora after BV treatment. The idea is straightforward: reintroduce the bacteria you want in order to crowd out the ones you do not. Lactobacilli are classified as generally safe and have been widely studied both as stand-alone treatments and as add-ons to antibiotic therapy.14PubMed Central. Use of probiotic lactobacilli in the treatment of vaginal infections: In vitro and in vivo investigations
One early clinical trial tested oral Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14 in women with BV. At doses of over 100 million viable organisms per day, twice-daily treatment was associated with a healthy vaginal flora in up to 90% of patients, and 7 out of 11 women with BV converted to normal or intermediate Nugent scores within a month.15PubMed. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora Data on supplementing antibiotic treatment with probiotics to improve cure rates and reduce recurrences has continued to accumulate since then.16PubMed Central. Vaginal microbiota and the use of probiotics Still, the evidence is mixed enough that most clinical guidelines stop short of formally recommending probiotics as a standard part of BV management. Many clinicians do discuss them as a reasonable option, especially for women dealing with frequent recurrences.
One thing to keep in mind: not all probiotic products are equal. The strains studied in clinical trials are specific, and a generic grocery-store yogurt or a supplement with different strains may not deliver the same benefit. If you are considering probiotics for recurrent BV, look for products containing strains that have actually been tested in vaginal health studies, and be skeptical of vague marketing claims.
Hormonal Changes and Their Effect on Vaginal Flora
Estrogen plays a quiet but essential role in maintaining a lactobacillus-dominant vaginal environment. Estrogen drives the vaginal epithelium to deposit glycogen, which lactobacilli then ferment into lactic acid, keeping the pH low and the environment inhospitable to anaerobes. When estrogen levels drop, as happens during menopause, this whole system weakens. Vaginal pH rises, lactobacilli decline, and the door opens for BV-associated organisms to move in.17PubMed Central. Bacterial Vaginosis in Postmenopausal Women
Animal research has added detail to this picture. In mice engineered to lack estrogen receptors in vaginal epithelial cells, researchers observed reduced glycogen, elevated vaginal pH, and a shift in the vaginal microbiome away from lactobacilli, changes that closely parallel postmenopausal dysbiosis in humans.18PubMed Central. Vaginal epithelial estrogen receptor α coordinates glycogen deposition, microbial stability, and pH regulation in mice This helps explain why postmenopausal women can develop a coccobacilli-predominant flora even without the behavioral risk factors commonly associated with BV in younger women. Local vaginal estrogen therapy is sometimes used to restore the glycogen-lactobacillus-acid chain, though discussion of that option is best had with your clinician.
Fluctuations during the menstrual cycle, hormonal contraception, and breastfeeding can also influence the balance, though typically less dramatically than menopause. The general principle holds: less estrogen activity in vaginal tissue means less glycogen, less acid, and a friendlier environment for coccobacilli.
Sexual Transmission and Partner Dynamics
BV has traditionally been classified as a non-sexually-transmitted condition, but that framing has become increasingly difficult to defend. Research on monogamous heterosexual couples where the woman has BV found that the bacterial communities on the male partner’s penile skin and in his urethra were significantly more similar to her vaginal microbiota than in couples without BV.19PubMed Central. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis This supports the idea that BV-associated bacteria are exchanged between partners during sex, which may help explain why having multiple sexual partners is a consistent risk factor and why BV recurs so often after treatment: the partner may harbor and reintroduce the same organisms.
Experimental models suggest Gardnerella vaginalis has both direct and indirect roles in BV, not just causing the condition itself but also facilitating colonization by other potential pathogens.20PubMed Central. Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models This “gateway” behavior makes the sexual-exchange question more than academic. If partners serve as reservoirs, treating only one partner and leaving the other untouched may set the stage for reinfection. Clinical trials investigating concurrent antibiotic treatment of male partners are ongoing, and some early results have been promising, though this is not yet standard practice.
When the Coccobacilli Are Not BV
It is worth noting that not every coccobacillus seen on a smear points to BV. Coccobacilli as a shape category include a wide range of organisms, some of which cause entirely different problems. Haemophilus influenzae, Bordetella pertussis, and Chlamydia trachomatis are all coccobacilli, though they cause respiratory or sexually transmitted infections rather than a simple vaginal flora shift. In hospital settings, Acinetobacter baumannii is a coccobacillus that causes serious healthcare-associated infections, particularly ventilator-associated pneumonia, and is classified by the World Health Organization as a Priority 1 pathogen due to rising antibiotic resistance.21IntechOpen. Treatment of Acinetobacter baumannii
On a vaginal Pap smear, though, the context narrows the possibilities considerably. The cytologist is not identifying a specific species; they are describing the overall pattern of bacteria they see. A “shift in flora consistent with bacterial vaginosis” is a pattern-recognition call, not a culture result. If your clinician suspects something other than garden-variety BV, they will order additional tests such as cultures, nucleic acid amplification tests, or wet mounts to pin down the specific organisms involved. For the vast majority of people who see “predominance of coccobacilli” on a Pap result, though, the conversation starts and usually ends with BV.